Skip to main content

Advertisement

Table 7 Optimal predicted HLA-I-restricted epitopes selected from HPV-33 E6 and E7

From: Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China

Target Protein Start Length Peptide Percentile Rank Binding Core in HLA-II predicted epitopes
HPV-33 E6 41 14 EVYDFAFADLTVVY 0.1 YDFAFADLT/DFAFADLTV/FAFADLTVV
42 14 VYDFAFADLTVVYR 0.1 YDFAFADLT/DFAFADLTV/FAFADLTVV
43 14 YDFAFADLTVVYRE 0.1 YDFAFADLT/DFAFADLTV/FAFADLTVV
44 14 DFAFADLTVVYREG 0.1 DFAFADLTV/FAFADLTVV
45 14 FAFADLTVVYREGN 0.1 FAFADLTVV
HPV-33 E7 52 10 YYIVTCCHTC 0.6 YYIVTCCHT
59 8 HTCNTTVR 0.6  
77 8 RTIQQLLM 0.1  
77 14 RTIQQLLMGTVNIV 0.5  
81 10 QLLMGTVNIV 0.55  
82 9 LLMGTVNIV 0.4  
  1. Note: The column of “Binding Core in HLA-II predicted epitopes” refers to the binding core of predicted HLA-II epitopes present in optimal HLA-I epitopes